Vaxjo: A web-based vaccine adjuvant database and its application for analysis of vaccine adjuvants and their uses in vaccine development

Journal of Biomedicine and Biotechnology

Volumn 2012, Issue , 2012, Pages

  Sayers, Samantha ^a,b   Ulysse, Guerlain ^b   Xiang, Zuoshuang ^a,b   He, Yongqun ^a,b,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; ALUMINUM PHOSPHATE; ALUMINUM POTASSIUM SULFATE; BRUCELLA VACCINE; CALCIUM PHOSPHATE; CHOLERA TOXIN; CHOLERA TOXIN B SUBUNIT; CORYNEBACTERIUM PARVUM VACCINE; DIPHTHERIA TOXIN; DNA VACCINE; ESCHERICHIA COLI VACCINE; FREUND ADJUVANT; INFLUENZA VACCINE; INTERLEUKIN 12; MIFAMURTIDE; MONTANIDE ISA 51; MONTANIDE ISA 720; PERTUSSIS VACCINE; QUIL A; SORBITAN ESTER; UNCLASSIFIED DRUG; VACCINE; IMMUNOLOGICAL ADJUVANT;

ARTICLE; BIOINFORMATICS; CONTACT ALLERGY; CPG ISLAND; DATA BASE; ERYTHEMA; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INJECTION SITE SWELLING; SKIN REDNESS; SUBCUTANEOUS NODULE; VAXJO; ANIMAL; COMPUTER INTERFACE; FACTUAL DATABASE; INTERNET; MEDICAL RESEARCH;

BRUCELLA;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BIOMEDICAL RESEARCH; DATABASE MANAGEMENT SYSTEMS; DATABASES, FACTUAL; HUMANS; INTERNET; USER-COMPUTER INTERFACE; VACCINES;

EID: 84859727707     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2012/831486     Document Type: Article

References (52)

1. Petrovsky N., Aguilar J. C., Vaccine adjuvants: current state and future trends Immunology and Cell Biology 2004 82 5 488 496 (Pubitemid 39421058)
2. Marciani D. J., Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity Drug Discovery Today 2003 8 20 934 943 (Pubitemid 37230013)
3. Ramon G., Sur l'augmentation anormale de l'antitoxine chez les chevaux producteurs de serum antidiphterique Bulletin de la Société Centrale de Médecine Vétérinaire 1925 101 227 234
4. Ramon G., Procedes pour accrotre la production des antitoxins Annales de l'Institut Pasteur 1926 40 1 10
5. Glenny A. T., Pope C. G., Waddington H., Wallace V., The antigenic value of toxoid precipitated by potassium-alum Journal of Pathology Bacteriology 1926 29 38 45
6. Freund J., Casals J., Hosmer E. P., Sensitization and antibody formation after injection of tubercle bacili and parafin oil Proceedings of the Society for Experimental Biology and Medicine 1937 37 509 513
7. Stuart-Harris C. H., Adjuvant influenza vaccines Bulletin of the World Health Organization 1969 41 3 617 621
8. Johnson A. G., Gaines S., Landy M., Studies on the O antigen of Salmonella typhosa. V. Enhancement of antibody response to protein antigens by the purified lipopolysaccharide The Journal of Experimental Medicine 1956 103 2 225 246
9. Ellouz F., Adam A., Ciorbaru R., Lederer E., Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives Biochemical and Biophysical Research Communications 1974 59 4 1317 1325
10. Vogel F. R., Powell M. F., Powell M. F., Newman M. J., A compendium of vaccine adjuvants and excipients Vaccine Design: The Subunit and Adjuvant Approach 1995 New York, NY, USA Plenum 141 228
11. Giannini S. L., Hanon E., Moris P., van Mechelen M., Morel S., Dessy F., Fourneau M. A., Colau B., Suzich J., Losonksy G., Martin M. T., Dubin G., Wettendorff M. A., Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only Vaccine 2006 24 33-34 5937 5949 (Pubitemid 44080367)
12. Cox J. C., Coulter A. R., Adjuvantsa classification and review of their modes of action Vaccine 1997 15 3 248 256 (Pubitemid 27116125)
13. Aguilar J. C., Rodrguez E. G., Vaccine adjuvants revisited Vaccine 2007 25 19 3752 3762 (Pubitemid 46589757)
14. Xiang Z., Todd T., Ku K. P., Kovacic B. L., Larson C. B., Chen F., Hodges A. P., Tian Y., Olenzek E. A., Zhao B., Colby L. A., Rush H. G., Gilsdorf J. R., Jourdian G. W., He Y., VIOLIN: vaccine investigation and online information network Nucleic Acids Research 2008 36 1 D923 D928
15. Xiang Z., Zheng W., He Y., BBP: brucella genome annotation with literature mining and curation BMC Bioinformatics 2006 7, article 347
16. Yang B., Sayers S., Xiang Z., He Y., Protegen: a web-based protective antigen database and analysis system Nucleic Acids Research 2011 39 supplement 1 D1073 D1078
17. He Y., Cowell.L, Diehl A. D., VO: Vaccine Ontology Proceedings of the 1st International Conference on Biomedical Ontology (ICBO '09) July 2009 Buffalo, NY, USA
18. Gupta R. K., Aluminum compounds as vaccine adjuvants Advanced Drug Delivery Reviews 1998 32 3 155 172 (Pubitemid 28267407)
19. Baylor N. W., Egan W., Richman P., Aluminum salts in vaccinesUS perspective Vaccine 2002 20 supplement 3 S18 S23
20. Coffman R. L., Sher A., Seder R. A., Vaccine adjuvants: putting innate immunity to work Immunity 2010 33 4 492 503
21. Bielinska A. U., Janczak K. W., Landers J. J., Markovitz D. M., Montefiori D. C., Baker J. R. Jr., Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces Th1 polarized responses and neutralizing antibodies to primary HIV type 1 isolates AIDS Research and Human Retroviruses 2008 24 2 271 281 (Pubitemid 351282102)
22. O'Hagan D. T., Rappuoli R., De Gregorio E., Tsai T., Del Giudice G., MF59 adjuvant: the best insurance against influenza strain diversity Expert Review of Vaccines 2011 10 4 447 462
23. Nicholls E. F., Madera L., Hancock R. E. W., Immunomodulators as adjuvants for vaccines and antimicrobial therapy Annals of the New York Academy of Sciences 2010 1213 1 46 61
24. Athanassiades T. J., Adjuvant effect of Bordetella pertussis vaccine to sheep erythrocytes in mice: enhancement of cell-mediated immunity by subcutaneous administration of adjuvant and antigen Infection and Immunity 1977 18 2 416 423 (Pubitemid 8232218)
25. Bauer S., Wagner H., Bacterial CpG-DNA licenses TLR9 Current Topics in Microbiology and Immunology 2002 270 145 154 (Pubitemid 35448158)
26. Leroux-Roels G., Unmet needs in modern vaccinology. Adjuvants to improve the immune response Vaccine 2010 28 supplement 3 C25 C36
27. Chen K., Cerutti A., Vaccination strategies to promote mucosal antibody responses Immunity 2010 33 4 479 491
28. Oppenheim J. J., Togawa A., Chedid L., Mizel S., Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factor Cellular Immunology 1980 50 1 71 81 (Pubitemid 10164222)
29. Pichichero M. E., Improving vaccine delivery using novel adjuvant systems Human Vaccines 2008 4 4 262 270
30. Bernhardt S. L., Gjertsen M. K., Trachsel S., Mller M., Eriksen J. A., Meo M., Buanes T., Gaudernack G., Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II study British Journal of Cancer 2006 95 11 1474 1482 (Pubitemid 44863349)
31. Song R., Liu S., Adams R. J., Leong K. W., Enhancing efficacy of HIV Gag DNA vaccine by local delivery of GM-CSF in murine and macaque models Journal of Interferon and Cytokine Research 2006 26 6 380 389 (Pubitemid 43856686)
32. Jain V., Vyas S. P., Kohli D. V., Well-defined and potent liposomal hepatitis B vaccines adjuvanted with lipophilic MDP derivatives Nanomedicine 2009 5 3 334 344
33. Burke R. L., Goldbeck C., Ng P., Stanberry L., Ott G., van Nest G., The influence of adjuvant on the therapeutic efficacy of a recombinant genital herpes vaccine The Journal of Infectious Diseases 1994 170 5 1110 1119 (Pubitemid 24328612)
34. Garon N., Segal L., Tavares F., van Mechelen M., The safety evaluation of adjuvants during vaccine development: the AS04 experience Vaccine 2011 29 27 4453 4459
35. MacLeod M. K., McKee A. S., David A., Wang J., Mason R., Kappler J. W., Marrack P., Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells Proceedings of the National Academy of Sciences of the United States of America 2011 108 19 7914 7919
36. He Y., Vemulapalli R., Schurig G. G., Recombinant Ochrobactrum anthropi expressing Brucella abortus Cu,Zn superoxide dismutase protects mice against B. abortus infection only after switching of immune responses to Th1 type Infection and Immunity 2002 70 5 2535 2543 (Pubitemid 34408398)
37. He Y., Vemulapalli R., Zeytun A., Schurig G. G., Induction of specific cytotoxic lymphocytes in mice vaccinated with Brucella abortus RB51 Infection and Immunity 2001 69 9 5502 5508 (Pubitemid 32786485)
38. Al-Mariri A., Tibor A., Mertens P., De Bolle X., Michel P., Godefroid J., Walravens K., Letesson J. J., Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant Infection and Immunity 2001 69 8 4816 4822 (Pubitemid 32674460)
39. Estevan M., Gamazo C., Grill M. J., del Barrio G. G., Blasco J. M., Irache J. M., Experiments on a sub-unit vaccine encapsulated in microparticles and its efficacy against Brucella melitensis in mice Vaccine 2006 24 19 4179 4187
40. Delpino M. V., Estein S. M., Fossati C. A., Baldi P. C., Cassataro J., Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice Vaccine 2007 25 37-38 6721 6729 (Pubitemid 47342467)
41. Mallick A. I., Singha H., Khan S., Anwar T., Ansari M. A., Khalid R., Chaudhuri P., Owais M., Escheriosome-mediated delivery of recombinant ribosomal L7/L12 protein confers protection against murine brucellosis Vaccine 2007 25 46 7873 7884 (Pubitemid 350011001)
42. Winter A. J., Rowe G. E., Duncan J. R., Eis M. J., Widom J., Ganem B., Morein B., Effectiveness of natural and synthetic complexes of porine and O polysaccharide as vaccines against Brucella abortus in mice Infection and Immunity 1988 56 11 2808 2817 (Pubitemid 18259932)
43. Delpino M. V., Estein S. M., Fossati C. A., Baldi P. C., Partial protection against Brucella infection in mice by immunization with nonpathogenic alphaproteobacteria Clinical and Vaccine Immunology 2007 14 10 1296 1301 (Pubitemid 350012971)
44. He Y., Reichow S., Ramamoorthy S., Ding X., Lathigra R., Craig J. C., Sobral B. W. S., Schurig G. G., Sriranganathan N., Boyle S. M., Brucella melitensis triggers time-dependent modulation of apoptosis and down-regulation of mitochondrion-associated gene expression in mouse macrophages Infection and Immunity 2006 74 9 5035 5046 (Pubitemid 44313715)
45. Cassataro J., Velikovsky C. A., Bruno L., Estein S. M., De La Barrera S., Bowden R., Fossati C. A., Giambartolomei G. H., Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting Clinical and Vaccine Immunology 2007 14 7 869 874
46. Bhattacharjee A. K., Izadjoo M. J., Zollinger W. D., Nikolich M. P., Hoover D. L., Comparison of protective efficacy of subcutaneous versus intranasal immunization of mice with a Brucella melitensis lipopolysaccharide subunit vaccine Infection and Immunity 2006 74 10 5820 5825 (Pubitemid 44484568)
47. Bhattacharjee A. K., van de Verg L., Izadjoo M. J., Yuan L., Hadfield T. L., Zollinger W. D., Hoover D. L., Protection of mice against brucellosis by intranasal immunization with Brucella melitensis lipopolysaccharide as a noncovalent complex with Neisseria meningitidis group B outer membrane protein Infection and Immunity 2002 70 7 3324 3329 (Pubitemid 34665966)
48. Cassataro J., Pasquevich K. A., Estein S. M., Laplagne D. A., Velikovsky C. A., de la Barrera S., Bowden R., Fossati C. A., Giambartolomei G. H., Goldbaum F. A., A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination Vaccine 2007 25 22 4437 4446 (Pubitemid 46695804)
49. Laplagne D. A., Zylberman V., Ainciart N., Steward M. W., Sciutto E., Fossati C. A., Goldbaum F. A., Engineering of a polymeric bacterial protein as a scaffold for the multiple display of peptides Proteins 2004 57 4 820 828 (Pubitemid 39627004)
50. Hunter R. L., Overview of vaccine adjuvants: present and future Vaccine 2002 20 supplement 3 S7 S12
51. Xiang Z., Courtot M., Brinkman R. R., Ruttenberg A., He Y., OntoFox: web-based support for ontology reuse BMC Research Notes 2010 3, article 175
52. Vogel F. R., Improving vaccine performance with adjuvants Clinical Infectious Diseases 2000 30 supplement 3 S266 S270